Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

RBC Capital Downgrades Avid Bioservices to Sector Perform, Raises Price Target to $12.5

Author: Benzinga Newsdesk | November 07, 2024 07:06am
RBC Capital analyst Sean Dodge downgrades Avid Bioservices (NASDAQ:CDMO) from Outperform to Sector Perform and raises the price target from $12 to $12.5.

Posted In: CDMO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist